TickerFacts.

Company research / RVTY

Revvity, Inc. (RVTY)

Build a valuation ↗↓ Download CSV

SEC name REVVITY, INC. · CIK 0000031791 · NYSE · Laboratory Analytical Instruments

  • Sector Manufacturing
  • Incorporated MA
  • Fiscal year ends around Dec 29

For the year ended 2025-12-28, Revvity, Inc. reported revenue of $2.86B. Revenue grew 3.7% from the prior annual period. Over the twelve months to 2026-07-05, revenue was $2.91B.

Key ratios (year ended 2025-12-28)

12.5%
Operating margin
8.4%
Net margin
3.3%
Return on year-end equity
3.7%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-02

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-07-05 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-07-05		2025-12-282024-12-292023-12-312023-01-01, Fiscal 20222022-01-02, Fiscal 20212021-01-03, Fiscal 20202019-12-292018-12-302017-12-312017-01-01, Fiscal 2016
Revenue$2.91B$2.86B$2.76B$2.75B$3.31B$3.83B$2.66B$2.88B$2.78B$2.26B$2.12B
Cost of Revenuen/an/an/an/an/an/an/an/a$1.44Bn/an/a
Gross Profitn/an/an/an/a$1.99B$2.43B$2.11B$1.40B$1.34B$1.07B$1.01B
R&D Expense$215.83M$215.84M$196.84M$216.58M$221.62M$200.34M$146.44M$189.34M$194.00M$139.46M$124.18M
Operating Income$358.85M$356.63M$346.74M$300.56M$742.70M$1.26B$867.27M$361.97M$323.88M$295.62M$294.58M
Depreciation & Amortization$412.24M$405.34M$427.85M$431.77M$427.00M$311.44M$201.65M$214.03M$180.59M$105.00M$99.97M
EBITDA$771.08M$761.98M$774.59M$732.33M$1.17B$1.57B$1.07B$576.00M$504.47M$400.62M$394.55M
Net Income$237.55M$241.20M$270.38M$693.09M$569.18M$943.16M$727.89M$227.56M$237.93M$292.63M$234.30M
EPS (Diluted)n/a$2.07$2.20$5.55$4.50$8.08$6.49$2.04$2.13$2.64$2.12
Total Assets$12.05B$12.17B$12.39B$13.56B$14.13B$15.00B$7.96B$6.54B$5.98B$6.09B$4.28B
Total Liabilities$4.82B$4.92B$4.73B$5.69B$6.75B$7.86B$4.22B$3.72B$3.39B$3.59B$2.12B
Long-Term Debtn/an/an/a$3.90B$4.39B$4.98B$1.99B$2.07B$1.89B$2.01B$1.05B
Shareholders' Equity$7.23B$7.25B$7.67B$7.87B$7.38B$7.14B$3.74B$2.81B$2.58B$2.50B$2.15B
Cash & Equivalents$1.02B$919.86M$1.16B$913.16M$454.36M$603.32M$387.05M$191.88M$163.11M$202.13M$359.26M
Operating Cash Flow$627.63M$582.93M$628.30M$91.27M$679.81M$1.41B$892.18M$363.47M$311.04M$288.45M$350.62M
Capital Expenditures$69.52M$73.52M$86.65M$81.37M$85.63M$86.02M$63.63M$76.33M$93.25M$39.09M$31.70M
Free Cash Flow$558.11M$509.41M$541.65M$9.90M$594.18M$1.32B$828.54M$287.14M$217.78M$249.36M$318.91M
Share Repurchases$475.80M$820.82M$369.58M$388.88M$80.64M$73.07M$6.94M$6.31M$57.45M$3.83M$151.80M
Dividends Paid$31.74M$32.80M$34.45M$34.97M$35.34M$32.37M$31.21M$31.06M$31.01M$30.79M$30.80M
Shares Outstanding111.58M112.28M120.65M123.43M126.30M126.24M112.09M111.14M110.36M110.36M109.62M
Dividends Per Sharen/a$0.28$0.28$0.28$0.28n/a$0.28$0.28$0.28$0.28$0.28
Weighted Average Diluted Sharesn/a116.59M122.82M124.81M126.43M116.67M112.08M111.50M111.53M110.86M110.31M
EPS (Basic)n/a$2.07$2.21$5.56$4.51$8.12$6.52$2.06$2.15$2.67$2.14

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView